"Researchers have identified a possible topical treatment for age-related
macular degeneration (AMD)," reports Science Daily. "The findings are the first to report
successful topical use of a compound with the potential to treat both
major forms of AMD, which can currently only be treated in later stages
with regular injections into the eye." Read more.